1994
DOI: 10.1016/s0021-9258(17)41836-9
|View full text |Cite
|
Sign up to set email alerts
|

3'-(p-azidobenzamido)taxol photolabels the N-terminal 31 amino acids of beta-tubulin.

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
1
1
1

Citation Types

2
66
0
2

Year Published

1995
1995
2021
2021

Publication Types

Select...
8
1

Relationship

0
9

Authors

Journals

citations
Cited by 238 publications
(70 citation statements)
references
References 29 publications
2
66
0
2
Order By: Relevance
“…These observations support the hypothesis that LPS and taxol share a common target in a signaling pathway controlled by the Lps gene (12). Although LPS and taxol may activate such a target directly from the cell surface, both enter cells rapidly (17,18) and bind specifically to [3-tubulin in a cell-free system (19)(20)(21). Thus, whether they are activated directly or indirectly, the common target of LPS and taxol may be MAP.…”
supporting
confidence: 73%
“…These observations support the hypothesis that LPS and taxol share a common target in a signaling pathway controlled by the Lps gene (12). Although LPS and taxol may activate such a target directly from the cell surface, both enter cells rapidly (17,18) and bind specifically to [3-tubulin in a cell-free system (19)(20)(21). Thus, whether they are activated directly or indirectly, the common target of LPS and taxol may be MAP.…”
supporting
confidence: 73%
“…The mechanism of stabilization is not known, but there have been two recent reports on crosslinking photoactive taxol derivatives to tubulin. One indicates that taxol interacts with an amino-terminal region (31 amino acids in length) of 3-tubulin [13], and the other indicates a 2.5-fold higher labeling of P-tubulin than a-tubulin [14]. It has also been reported that microtubules assembled in the presence of taxol tend to have 12, rather than 13, protofilaments [15,16].…”
Section: Introductionmentioning
confidence: 99%
“…Our data confirmed additivity in those cells lines that undergo paclitaxel-induced ERK activation, and antagonism in cells with low ERK activity, suggesting that in tumors with high ERK activity, there may be an application for this strategy in therapy.Paclitaxel (Taxol) is a widely used cancer chemotherapeutic drug that exhibits clinical activity in a range of human malignancies (Arbuck et al, 1993) and is being extensively evaluated in ongoing trials as a single agent (Malingre et al, 2000) and in combination therapy (Piccart et al, 2000). The binding site for paclitaxel on ÎČ-tubulin has been assigned from photoaffinity labeling experiments (Rao et al, 1994(Rao et al, , 1995(Rao et al, , 1999 and from the electron crystallography model in which the αand ÎČ-tubulin dimer is fitted to a 3.7-Å density map (Nogales et al, 1998). In addition to its ability to bind to microtubules, paclitaxel also has been shown to interact with bcl-2 (Rodi et al, 1999) and to phosphorylate both bcl-2 and…”
mentioning
confidence: 99%